11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cyclase-associated protein 2 dimerization regulates cofilin in synaptic plasticity and Alzheimer's disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Regulation of actin cytoskeleton dynamics in dendritic spines is crucial for learning and memory formation. Hence, defects in the actin cytoskeleton pathways are a biological trait of several brain diseases, including Alzheimer's disease. Here, we describe a novel synaptic mechanism governed by the cyclase-associated protein 2, which is required for structural plasticity phenomena and completely disrupted in Alzheimer's disease. We report that the formation of cyclase-associated protein 2 dimers through its Cys 32 is important for cyclase-associated protein 2 binding to cofilin and for actin turnover. The Cys 32-dependent cyclase-associated protein 2 homodimerization and association to cofilin are triggered by long-term potentiation and are required for long-term potentiation-induced cofilin translocation into spines, spine remodelling and the potentiation of synaptic transmission. This mechanism is specifically affected in the hippocampus, but not in the superior frontal gyrus, of both Alzheimer's disease patients and APP/PS1 mice, where cyclase-associated protein 2 is down-regulated and cyclase-associated protein 2 dimer synaptic levels are reduced. Notably, cyclase-associated protein 2 levels in the cerebrospinal fluid are significantly increased in Alzheimer's disease patients but not in subjects affected by frontotemporal dementia. In Alzheimer's disease hippocampi, cofilin association to cyclase-associated protein 2 dimer/monomer is altered and cofilin is aberrantly localized in spines. Taken together, these results provide novel insights into structural plasticity mechanisms that are defective in Alzheimer's disease.

          Abstract

          Long-term potentiation triggers cyclase-associated protein 2 translocation to spines, the formation of Cys 32-dependent CAP2 dimers and binding to cofilin, thus leading to an increase in cofilin synaptic localization. In Alzheimer's disease, patients’ synapses this pathway is altered: cyclase-associated protein 2 dimer is reduced and aberrantly associated to cofilin, while cofilin synaptic localization is increased.

          Graphical Abstract

          Graphical Abstract

          Related collections

          Most cited references75

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            lmerTest Package: Tests in Linear Mixed Effects Models

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The clinical use of structural MRI in Alzheimer disease.

              Structural imaging based on magnetic resonance is an integral part of the clinical assessment of patients with suspected Alzheimer dementia. Prospective data on the natural history of change in structural markers from preclinical to overt stages of Alzheimer disease are radically changing how the disease is conceptualized, and will influence its future diagnosis and treatment. Atrophy of medial temporal structures is now considered to be a valid diagnostic marker at the mild cognitive impairment stage. Structural imaging is also included in diagnostic criteria for the most prevalent non-Alzheimer dementias, reflecting its value in differential diagnosis. In addition, rates of whole-brain and hippocampal atrophy are sensitive markers of neurodegeneration, and are increasingly used as outcome measures in trials of potentially disease-modifying therapies. Large multicenter studies are currently investigating the value of other imaging and nonimaging markers as adjuncts to clinical assessment in diagnosis and monitoring of progression. The utility of structural imaging and other markers will be increased by standardization of acquisition and analysis methods, and by development of robust algorithms for automated assessment.
                Bookmark

                Author and article information

                Journal
                Brain Commun
                Brain Commun
                braincomms
                Brain Communications
                Oxford University Press
                2632-1297
                2020
                26 June 2020
                26 June 2020
                : 2
                : 2
                : fcaa086
                Affiliations
                [f1 ] Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano , Milan, Italy
                [f2 ] Department of Neurosciences, Psychology, Drug Research, and Child Health, University of Florence , Florence, Italy
                [f3 ] Department of Biotechnology and Translational Medicine, Università degli Studi di Milano , Milan, Italy
                [f4 ] Department of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University , INF 366 69120, Heidelberg, Germany
                [f5 ] Emmy-Noether Group “Neuronal Protein Transport”, Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf (UKE), Falkenried 94, 20251, Hamburg, Germany
                [f6 ] Neurology Unit, Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia , Brescia, Italy
                [f7 ] Faculty of Medicine, Molecular Neurobiology Group, Institute of Physiological Chemistry, University of Marburg , Marburg, Germany
                [f8 ] DFG Research Training Group, Membrane Plasticity in Tissue Development and Remodeling, GRK 2213, Philipps-University of Marburg , 35032, Marburg, Germany
                [f9 ] Center for Mind, Brain and Behavior (CMBB), University of Marburg and Justus-Liebig-University Giessen , Hans-Meerwein-Strasse 6, 35032, Marburg, Germany
                [f10 ] Department of Life and Environmental Sciences, New York-Marche Structural Biology Center (NY-MaSBiC), Polytechnic University of Marche , Via Brecce Bianche, Ancona, Italy
                [f11 ]Research Group “Optobiology”, Institute for Biology, Humboldt-Universität zu Berlin , Invalidenstraße 42, 10115 Berlin, Germany
                [f12 ]Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry, and Epidemiology “G.A. Maccacaro”, Università degli Studi di Milano , Milan, Italy
                Author notes

                Silvia Pelucchi and Lina Vandermeulen are the co-first authors.

                Monica Di Luca and Elena Marcello are the co-senior authors.

                Correspondence to: Monica Di Luca, Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, via Balzaretti 9, 20133 Milan, Italy E-mail: monica.diluca@ 123456unimi.it
                Author information
                http://orcid.org/0000-0003-4723-8510
                http://orcid.org/0000-0001-5878-0554
                http://orcid.org/0000-0003-2737-1250
                http://orcid.org/0000-0003-1225-4633
                http://orcid.org/0000-0002-1995-1477
                Article
                fcaa086
                10.1093/braincomms/fcaa086
                7566557
                33094279
                d4f518a6-4ceb-48d9-ab8d-d9cd47c2ac6f
                © The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 24 January 2020
                : 24 April 2020
                : 28 April 2020
                Page count
                Pages: 25
                Funding
                Funded by: European Union’s Horizon 2020 research and innovation program;
                Funded by: Marie Skłodowska-Curie;
                Award ID: 676144
                Funded by: Italian Ministry of Education;
                Funded by: University and Research (MIUR);
                Award ID: 2015N4FKJ4
                Award ID: 2017B9NCSX
                Funded by: Fondazione Cariplo, DOI 10.13039/501100002803;
                Award ID: 2018—0511
                Funded by: intramural grant of University of Milan;
                Award ID: 2—PSR2015-1716GRACA02_05_M
                Award ID: PSR2017_DIP_022_03
                Award ID: PSR2019_EMARC
                Award ID: PSR2015-1719FBRAV
                Funded by: Deutsche Forschungsgemeinschaft (DFG);
                Award ID: FOR2419
                Funded by: MIUR - PON ‘Ricerca e Innovazione’ PerMedNet project;
                Award ID: ARS01_01226
                Categories
                Original Article
                AcademicSubjects/MED00310
                AcademicSubjects/SCI01870

                dementia,synapse,actin,cytoskeleton
                dementia, synapse, actin, cytoskeleton

                Comments

                Comment on this article